Generali


2021 plan (certainly) delivered, all eyes on the new one and the CEO

21/11/21 -"Generali, in continuity of most insurers’ results releases, is on track to deliver on its FY objective as well as its 3-year strategic plan. All eyes are now turned towards the CMD to be held on 15 ..."

Pages
66
Language
English
Published on
21/11/21
You may also be interested by these reports :
26/03/24
• Net profit attributable to shareholders decreased by 3% to CHF240m for 2023 • RoE was 7.4% for FY2023 compared to 6.7% for FY2022 • The dividend ...

26/03/24
Our recommendation returns to “Add” from “Reduce”, with Generali remaining one of our top picks as shown by the stock’s inclusion in our Active List. ...

21/03/24
M&G delivered strong FY23 results, surpassing estimates across the board, largely due to higher investment income. We acknowledge the company’s ...

14/03/24
• Net profit attributable to shareholders increased by 8% to CHF1.11bn for 2023 • Insurance revenues were up by 10% to CHF8.8bn for 2023 • The RoE ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO